Announcements Trials
Browse Landscape

Status

Unknown 2Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 12Observational 2

Sponsor

Cancer Type

Other solid neoplasm 1Gynecologic 1

Conditions

Carcinoma, Ovarian Epithelial 1Advanced Solid Tumor 1

Interventions

Observation 21Blood Specimen Collection 20Drug Therapy 13Surveys and Questionnaires 8Surgical Procedures, Operative 8Immunotherapy 7Immune Checkpoint Inhibitors 7Positron Emission Tomography Computed Tomography 5Hematologic Tests 5Watchful Waiting 4Neoadjuvant Therapy 4Fluorodeoxyglucose F18 4Bevacizumab 4darolutamide 3Tyrosine Kinase Inhibitors 3Therapeutics 3Standard of Care 3Radiotherapy 3Indocyanine Green 3Imatinib Mesylate 3Endoscopic Mucosal Resection 3Docetaxel 3Cyclophosphamide 3Capecitabine 3Artificial Intelligence 3tislelizumab 2pertuzumab 2palbociclib 2obinutuzumab 2nilotinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Observational × envafolimab × Clear all
NCT07562347 2026-05-01

ENCOMPASS STUD

IR INNOVATE RESEARCH PRIVATE LIMITED

Not yet recruiting
120 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06010667 2023-08-24

A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer

Hebei Medical University Fourth Hospital

Not yet recruiting
60 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡